Home/Clinical Trials
RecruitingPhase 2CT-2026-121
Gene therapy CLV-508 in ambulatory boys with Duchenne
Duchenne muscular dystrophy · Rare Disease
Ages 4 to 17 years230 participantsSydney, Australia, Houston, TX
RecruitingPhase 1CT-2025-122
CLV-515 in adults with Fabry disease
Fabry disease · Rare Disease
Ages 18 years and older80 participantsSeoul, South Korea, San Diego, CA +2 more
Active, not recruitingPhase 3CT-2024-123
Elvoparvec 15-year follow-up registry
Spinal muscular atrophy · Rare Disease
Ages 18 to 75 years2,140 participantsSydney, Australia, Boston, MA +2 more
Not yet recruitingPhase 2CT-2026-129
CLV-508 in non-ambulatory patients
Duchenne muscular dystrophy · Rare Disease
Ages 18 years and older210 participantsLondon, UK, San Diego, CA +1 more
Study listings are fictional. Talk with your doctor before joining any clinical trial.